基本信息
浏览量:570
职业迁徙
个人简介
In 1994, he went abroad to NCI in the United States to do basic research for the development of investigational new drugs, especially for molecular targeted drugs. In 1997, Prof. Nakagawa moved back to Osaka as an Instructor and later became full Professor in the Department of Medical Oncology at the Kinki University Faculty of Medicine in 2007. His research interests include novel therapies for lung cancer.
Since 2011, Prof. Nakagawa has been playing the role as a director of IASLC and actively contributing to the development of cancer treatment not only in Japan but internationally. He is also the board liaison of Career Development Committee and Continuing Medical Education Committee of IASLC. In addition, he is a director of JLCS (Japan Lung Cancer Society) and JSMO (Japanese Society of Medical Oncology), the Vice President of WJOG (West Japan Oncology Group) and the chair of its Thoracic Oncology Committee. He has been involved in a number of WJOG clinical trials and playing the role as Principal Investigator. In 2012, he has organized 10th Annual Meeting of JSMO as the Congress President, which has been successfully held in Osaka and gathered 4,821 people from 13 different countries. He also plays the role of Principle Investigator in a number of clinical trials in Japan, which are federally-supported, and has published the clinical and translational research works extensively on the various scientific international journals.
Since 2011, Prof. Nakagawa has been playing the role as a director of IASLC and actively contributing to the development of cancer treatment not only in Japan but internationally. He is also the board liaison of Career Development Committee and Continuing Medical Education Committee of IASLC. In addition, he is a director of JLCS (Japan Lung Cancer Society) and JSMO (Japanese Society of Medical Oncology), the Vice President of WJOG (West Japan Oncology Group) and the chair of its Thoracic Oncology Committee. He has been involved in a number of WJOG clinical trials and playing the role as Principal Investigator. In 2012, he has organized 10th Annual Meeting of JSMO as the Congress President, which has been successfully held in Osaka and gathered 4,821 people from 13 different countries. He also plays the role of Principle Investigator in a number of clinical trials in Japan, which are federally-supported, and has published the clinical and translational research works extensively on the various scientific international journals.
研究兴趣
论文共 1020 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JTO Clinical and Research Reportsno. 2 (2024): 100624-100624
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2301017-JCO2301017, (2024)
The Lancet Oncologyno. 4 (2024): 439-454
Translational lung cancer researchno. 8 (2023): 1702-1716
引用0浏览0WOS引用
0
0
crossref(2023)
Cancer medicineno. 23 (2023): 21097-21110
Kunio Okamoto,Isamu Okamoto,Wataru Okamoto,Kaoru Tanaka, Ken Takezawa, Kiyoko Kuwata,Haruka Yamaguchi,Kazuto Nishio,Kazuhiko Nakagawa
crossref(2023)
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 8544-8544
引用0浏览0引用
0
0
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn